Use access key #2 to skip to page content.
$51.78 1.43 (2.84%)
12/3/2008 4:05 PM

Novo Nordisk A/S (ADR) (NVO)

CAPS Rating:
*****

Engaged in discovery, development, manufacturing and marketing of pharmaceutical products and has two business segments - diabetes care and biopharmaceuticals.

View All Commentary (NVO)

Recs

0

Avatar jdlech (< 20) Submitted: 7/12/08 12:44 AM : Outperform Start Price: $64.66 NVO Score: 10.93

dividend yielding pharma.

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links